Treatment of invasive candidiasis in non-haematological patients
Treatment of invasive candidiasis in non-haematological patients Treatment of invasive candidiasis in non-haematological patients
from sbimc.org
More from this publisher
11.07.2015
Views
EpidemiologyMainly data from the USA or from individual EuropeancountriesTrick Clin Infect Dis 2002
- Page 6 and 7: Candidemia incidence in LeuvenLagro
- Page 8 and 9: Question1 : Which Candida species i
- Page 10 and 11: | Advisory board Anidulafungin, Nov
- Page 12 and 13: Time to start antifungal therapy& h
- Page 14 and 15: Question 2: Which factor has the gr
- Page 16 and 17: Prediction rules- Paphitou: TPN, he
- Page 18 and 19: Identify patients for empirical/pre
- Page 20 and 21: Question3: What’s the problem wit
- Page 22 and 23: Identify patients for empirical/pre
- Page 24 and 25: Question 4: Empirical treatment is
- Page 26 and 27: Appropriate empirical treatment in
- Page 28 and 29: Antifungal prophylaxis in the ICU?P
- Page 30 and 31: Outcome empirical therapy in ICUOut
- Page 32 and 33: Time to start antifungal therapy& h
- Page 34 and 35: Antifungal agentsAmphotericin B•
- Page 36 and 37: SusceptibilityAntfungal Albicans Gl
- Page 38 and 39: Caspofungin vs. AmB in ICU Patients
- Page 40 and 41: Micafungin vs. L-AmB in ICU Patient
- Page 42 and 43: Survival in ICU patients:anidulafug
- Page 44 and 45: Indications per echinocandinWagner,
- Page 46 and 47: Question 5: Should the intravascula
- Page 48 and 49: Andes pooled data analysis1915 pati
- Page 50 and 51: Treatment of invasive candidiasis i
EpidemiologyMa<strong>in</strong>ly data from the USA or from <strong>in</strong>dividual EuropeancountriesTrick Cl<strong>in</strong> Infect Dis 2002
Change language